Immage Financial Statements From 2010 to 2026
| IMMG Stock | | | USD 0.0001 0.00 0.00% |
Immage Biotherapeutics' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Immage Biotherapeutics' valuation are provided below:
Market Capitalization | Earnings Share |
There are over eighty-one available fundamental trends for Immage Biotherapeutics, which can be analyzed over time and compared to other ratios. Active traders should verify all of Immage Biotherapeutics regular fundamental drivers against the trend between
2010 and 2026 to make sure the company can sustain itself down the road. The Immage Biotherapeutics' current
Market Cap is estimated to increase to 137.31, while
Working Capital is projected to decrease to (28.9
K).
Check out the analysis of
Immage Biotherapeutics Correlation against competitors.
Immage Biotherapeutics Balance Sheet | | |
|
Immage Biotherapeutics Income Statement | | |
|
Immage Biotherapeutics Cash Flow Statement | | |
|
Financial Ratios | | |
|
Immage Biotherapeutics Valuation Data | | |
| Current Value | Last Year | Historical Average | 10 Year Trend |
|---|
| Market Cap | 137 | 131 | 102 | |
|
About Immage Biotherapeutics Financial Statements
Immage Biotherapeutics stakeholders use historical fundamental indicators, such as Immage Biotherapeutics' revenue or net income, to determine how well the company is positioned to perform in the future. Although Immage Biotherapeutics investors may analyze each financial statement separately, they are all interrelated. For example, changes in Immage Biotherapeutics' assets and liabilities are reflected in the revenues and expenses on Immage Biotherapeutics' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Immage Biotherapeutics Corp. Please read more on our
technical analysis and
fundamental analysis pages.
| | Last Reported | Projected for Next Year |
Currently Active Assets on Macroaxis
When determining whether Immage Biotherapeutics is a strong investment it is important to analyze Immage Biotherapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Immage Biotherapeutics'
future performance.
For an informed investment choice regarding Immage Stock, refer to the following important reports: Check out the analysis of
Immage Biotherapeutics Correlation against competitors.
You can also try the
Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Can Biotechnology industry sustain growth momentum? Does Immage have expansion opportunities? Factors like these will boost
the valuation of Immage Biotherapeutics. Market participants price Immage higher when confident in its future expansion prospects. Determining accurate worth demands scrutiny of both present operating results and projected expansion capacity. Evaluating Immage Biotherapeutics demands reviewing these metrics collectively while recognizing certain factors exert disproportionate influence.
Earnings Share | Return On Assets | Return On Equity |
Immage Biotherapeutics's market price often diverges from its book value, the accounting figure shown on Immage's balance sheet. Smart investors calculate
Immage Biotherapeutics' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Market participants employ diverse analytical approaches to determine fair value and identify buying opportunities when prices dip below calculated worth. Since Immage Biotherapeutics' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Immage Biotherapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine
if Immage Biotherapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immage Biotherapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.